To provide for the periodic issuance of up-to-date clinical guidance on addressing the health effects of per- and polyfluoroalkyl substances (PFAS), and for other purposes.
About This Bill
Committee
Latest Action · December 8, 2023
Referred to the Subcommittee on Environment, Manufacturing, and Critical Materials.